These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8094594)

  • 1. A Symposium: Antioxidants and Lipid Metabolism. Proceedings. April 11, 1992.
    Am J Cardiol; 1993 Feb; 71(6):1B-42B. PubMed ID: 8094594
    [No Abstract]   [Full Text] [Related]  

  • 2. Atherosclerosis: cell biology and lipoproteins.
    Wahle KW
    Curr Opin Lipidol; 2003 Oct; 14(5):545-8. PubMed ID: 14501595
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapy and clinical trials.
    Dutta-Roy AK
    Curr Opin Lipidol; 1996 Feb; 7(1):U34-7. PubMed ID: 8925178
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of antioxidants against atherosclerosis.
    Niki E; Noguchi N
    Mol Cell Biochem; 2002; 234-235(1-2):19-25. PubMed ID: 12162433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress, antioxidants, and cardiovascular disease.
    Violi F; Cangemi R; Brunelli A
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):e37; author reply e37. PubMed ID: 15790938
    [No Abstract]   [Full Text] [Related]  

  • 6. [Biochemical aspects of atherogenesis: the role of antioxidants].
    Dmitriev LF
    Ter Arkh; 1995; 67(12):73-7. PubMed ID: 8820067
    [No Abstract]   [Full Text] [Related]  

  • 7. [Current aspects of arteriosclerosis treatment].
    Voskresenskiĭ ON; Bobyrev VN; Malik VV
    Vrach Delo; 1984 Aug; (8):4-10. PubMed ID: 6390960
    [No Abstract]   [Full Text] [Related]  

  • 8. Lipoprotein oxidation as a mediator of atherogenesis: insights from pharmacological studies.
    Daugherty A; Roselaar SE
    Cardiovasc Res; 1995 Mar; 29(3):297-311. PubMed ID: 7781006
    [No Abstract]   [Full Text] [Related]  

  • 9. [Correction of biochemical disorders in the lipid metabolism of atherosclerosis patients by using the antioxidant dibunol].
    Barsel' VA; Korochkin IM; Arkhipova GV; Sal'nikov MI; Matveeva SA
    Izv Akad Nauk SSSR Biol; 1988; (1):75-85. PubMed ID: 3351102
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antioxidants, oxidation of LDL and atherosclerosis].
    Salonen JT; Kovanen PT; Ylä-Herttuala S; Korpela H
    Duodecim; 1991; 107(15):1232-9. PubMed ID: 1365345
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antioxidant probucol is an efficient trap for lipid radicals in LDL in vitro and in vivo].
    Tikhaze AK; Lankin VZ; Konovalova GG; Shumaev KB; Kaminnyĭ AI; Kozachenko AI; Gurevich SM; Nagler LG; Zaĭtseva TM; Kukharchuk VV
    Biull Eksp Biol Med; 1999 Aug; 127(8):186-9. PubMed ID: 11188741
    [No Abstract]   [Full Text] [Related]  

  • 12. [New pharmaceuticals for patients with atherosclerosis are under development. Antioxidants inhibit LDL modification].
    Björkhem I; Berglund L
    Lakartidningen; 1989 Sep; 86(39):3249-50, 3255. PubMed ID: 2796509
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of a protein synthesis inhibitor (olivomycin) on the development of experimental atherosclerosis in rabbits].
    Frol'kis VV; Bogatskaia LN; Novikova SN
    Fiziol Zh (1978); 1987; 33(4):3-8. PubMed ID: 3622809
    [No Abstract]   [Full Text] [Related]  

  • 14. [The oxidative hypothesis of atherosclerosis and the use of antioxidants in coronary disease].
    Batlouni M
    Arq Bras Cardiol; 1997 Jan; 68(1):55-63. PubMed ID: 9334462
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of retabolyl on the lipid and protein metabolism of coronary atherosclerosis patients].
    Savenkov PM; Segal' RG
    Kardiologiia; 1969 Jul; 9(7):95-100. PubMed ID: 5372695
    [No Abstract]   [Full Text] [Related]  

  • 16. [The significance of oxidized lipoproteins for the development of atherosclerosis. Antioxidants as a therapeutic alternative in atherosclerosis].
    Boberg KM
    Tidsskr Nor Laegeforen; 1991 Jun; 111(15):1861-5. PubMed ID: 1853321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antioxidants in complex therapy of atherosclerosis: pro et contra].
    Lankin VZ; Tikhaze AK; Belenkov IuN
    Kardiologiia; 2004; 44(2):72-81. PubMed ID: 15029140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lipids and lipoproteins in early changes of arteriosclerosis].
    Smith EB
    Z Gesamte Inn Med; 1978 Sep; 33(17):605-6. PubMed ID: 30219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interdependence of fat and carbohydratex metabolism disorders in arteriosclerosis].
    Gola A
    Postepy Hig Med Dosw; 1967; 21(1):119-43. PubMed ID: 6044662
    [No Abstract]   [Full Text] [Related]  

  • 20. [Modified lipoproteins and atherogenesis].
    Fruchart JC; Sauzières J; Plancke MO; Luc G; Clavey V
    Presse Med; 1989 Apr; 18(14):701-2. PubMed ID: 2524746
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.